Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R–mediated apoptosis
Thomas Condamine, … , Thomas Bauer, Dmitry I. Gabrilovich
Thomas Condamine, … , Thomas Bauer, Dmitry I. Gabrilovich
Published May 1, 2014
Citation Information: J Clin Invest. 2014;124(6):2626-2639. https://doi.org/10.1172/JCI74056.
View: Text | PDF
Research Article Immunology Article has an altmetric score of 24

ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R–mediated apoptosis

  • Text
  • PDF
Abstract

Myeloid-derived suppressor cells (MDSCs) dampen the immune response thorough inhibition of T cell activation and proliferation and often are expanded in pathological conditions. Here, we studied the fate of MDSCs in cancer. Unexpectedly, MDSCs had lower viability and a shorter half-life in tumor-bearing mice compared with neutrophils and monocytes. The reduction of MDSC viability was due to increased apoptosis, which was mediated by increased expression of TNF-related apoptosis–induced ligand receptors (TRAIL-Rs) in these cells. Targeting TRAIL-Rs in naive mice did not affect myeloid cell populations, but it dramatically reduced the presence of MDSCs and improved immune responses in tumor-bearing mice. Treatment of myeloid cells with proinflammatory cytokines did not affect TRAIL-R expression; however, induction of ER stress in myeloid cells recapitulated changes in TRAIL-R expression observed in tumor-bearing hosts. The ER stress response was detected in MDSCs isolated from cancer patients and tumor-bearing mice, but not in control neutrophils or monocytes, and blockade of ER stress abrogated tumor-associated changes in TRAIL-Rs. Together, these data indicate that MDSC pathophysiology is linked to ER stress, which shortens the lifespan of these cells in the periphery and promotes expansion in BM. Furthermore, TRAIL-Rs can be considered as potential targets for selectively inhibiting MDSCs.

Authors

Thomas Condamine, Vinit Kumar, Indu R. Ramachandran, Je-In Youn, Esteban Celis, Niklas Finnberg, Wafik S. El-Deiry, Rafael Winograd, Robert H. Vonderheide, Nickolas R. English, Stella C. Knight, Hideo Yagita, Judith C. McCaffrey, Scott Antonia, Neil Hockstein, Robert Witt, Gregory Masters, Thomas Bauer, Dmitry I. Gabrilovich

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Total
Citations: 11 26 21 26 30 33 22 18 16 14 9 6 232
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (232)

Title and authors Publication Year
Designer extracellular vesicles with DR5-agonistic-scFvs simultaneously target tumor and immune suppressive cells in solid tumors
Yeye Guo, Huaishan Wang, Shujing Liu, Xiaogang Zhang, Xingyue Zhu, Lili Huang, Wenqun Zhong, Lei Guan, Yeqing Chen, Min Xiao, Lingling Ou, Jingbo Yang, Gerald Linette, Alexander Huang, Tara Mitchell, Ravi Amaravadi, Giorgos Karakousis, John Miura, Lynn Schuchter, Ahron Flowers, Qiuxian Zheng, Haiwei Mou, Phyllis Gimotty, Meenhard Herlyn, Wei Guo, Xiaowei Xu
Science advances 2025
Endoplasmic Reticulum Stress: Triggers Microenvironmental Regulation and Drives Tumor Evolution
Peng C, Wang J, Wang S, Zhao Y, Wang H, Wang Y, Ma Y, Yang J
Cancer Medicine 2025
MDSC checkpoint blockade therapy: a new breakthrough point overcoming immunosuppression in cancer immunotherapy
Ibrahim A, Mohamady Farouk Abdalsalam N, Liang Z, Kashaf Tariq H, Li R, O. Afolabi L, Rabiu L, Chen X, Xu S, Xu Z, Wan X, Yan D
Cancer Gene Therapy 2025
Unraveling the Complexities of Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease
Zhu Y, Cao S
International Journal of Molecular Sciences 2025
Role of EFNAs in Shaping the Tumor Immune Microenvironment and Their Impact on Pancreatic Adenocarcinoma Prognosis
Li YC, Zhang L, Wang YT, Hu H, Zhang ZY, Nie QQ, Zuo CJ
Cancer Management and Research 2025
MiR- 150 deletion promotes lung tumor growth by upregulating P-STAT3 and ROS in MDSCs
Qin A, Chen H, Xu F, Li W, Guo S, Zhang G, Zhang A, Zheng A, Tian F, Zheng Q
Scientific Reports 2025
Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy.
Toghraie FS, Bayat M, Hosseini MS, Ramezani A
Cellular oncology (Dordrecht, Netherlands) 2025
Myeloid cells: key players in tumor microenvironments.
Hua Q, Li Z, Weng Y, Wu Y, Zheng L
Frontiers of medicine 2025
The heterogeneity of neutrophils in cancer and its implication for therapeutic targeting
Eruslanov E, Nefedova Y, Gabrilovich DI
Nature immunology 2025
Targeting neutrophils for cancer therapy.
Kwak JW, Houghton AM
Nature reviews. Drug discovery 2025
Myeloid‐Derived Suppressor Cells in Cancer: Mechanistic Insights and Targeted Therapeutic Innovations
Hu T, Zhai J, Yang Z, Peng J, Wang C, Liu X, Li Y, Yao J, Chen F, Li H, An T, Liu Z, Wang H
MedComm 2025
Noncanonical TRAIL signaling promotes myeloid-derived suppressor cell abundance and tumor progression in cholangiocarcinoma
Emilien Loeuillard, Binbin Li, Hannah Stumpf, Jingchun Yang, Jessica Willhite, Jennifer Tomlinson, Juan Wang, Fariborz Rakhshan Rohakhtar, Vernadette Simon, Rondell Graham, Rory Smoot, Haidong Dong, Sumera Ilyas
Cellular and Molecular Gastroenterology and Hepatology 2024
Myeloid-derived suppressor cells in cancer and cancer therapy.
Lasser SA, Ozbay Kurt FG, Arkhypov I, Utikal J, Umansky V
Nature reviews. Clinical oncology 2024
Targeting PMN-MDSCs via CD300ld receptor for cancer immunotherapy.
Li Y, Wang C, Lu Z, Luo M
Clinical and Translational Medicine 2024
粒细胞样髓源性抑制细胞在非小细胞肺癌中的研究进展
YANG C, ZHU R, ZHANG Y, YING L, WANG J, LIU P, SU D
2024
Immune cell networking in solid tumors: focus on macrophages and neutrophils.
Di Ceglie I, Carnevale S, Rigatelli A, Grieco G, Molisso P, Jaillon S
Frontiers in immunology 2024
Carbon Ion Irradiation Activates Anti-Cancer Immunity
Sudo M, Tsutsui H, Fujimoto J
International journal of molecular sciences 2024
MDSC expansion during HIV infection: regulators, ART and immune reconstitution.
Yaseen MM, Abuharfeil NM, Darmani H
Genes and Immunity 2024
Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion.
Lu J, Luo Y, Rao D, Wang T, Lei Z, Chen X, Zhang B, Li Y, Liu B, Xia L, Huang W
Experimental Hematology and Oncology 2024
CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies
Niu Z, Wu J, Zhao Q, Zhang J, Zhang P, Yang Y
Frontiers in immunology 2024
Tumor-associated neutrophils upregulate Nectin2 expression, creating the immunosuppressive microenvironment in pancreatic ductal adenocarcinoma
Haizhen Luo, Naoki Ikenaga, Kohei Nakata, Nobuhiro Higashijima, Pingshan Zhong, Akihiro Kubo, Chenyi Wu, Chikanori Tsutsumi, Yuki Shimada, Masataka Hayashi, Koki Oyama, Satomi Date, Toshiya Abe, Noboru Ideno, Chika Iwamoto, Koji Shindo, Kenoki Ohuchida, Yoshinao Oda, Masafumi Nakamura
Journal of experimental & clinical cancer research : CR 2024
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Lin H, Liu C, Hu A, Zhang D, Yang H, Mao Y
Journal of Hematology & Oncology 2024
Knock down of APE1 suppressed gastric cancer metastasis via improving immune disorders caused by myeloid-derived suppressor cells
Zhang B, Tang Q, Shi W, Bao Z, Gao S, Pan C
Cell cycle (Georgetown, Tex.) 2024
Tumour Microenvironment: The General Principles of Pathogenesis and Implications in Diffuse Large B Cell Lymphoma
Sinkarevs S, Strumfs B, Volkova S, Strumfa I
Cells 2024
DDIT3 is associated with breast cancer prognosis and immune microenvironment: an integrative bioinformatic and immunohistochemical analysis
Yu X, Li W, Sun S, Li J
Journal of Cancer 2024
Targeting CD300ld to normalize the tumor microenvironment: an emerging insight in cancer immunotherapy
Zhang L, He X, Zhu H
MedComm 2024
PPP1R15A-expressing monocytic MDSCs promote immunosuppressive liver microenvironment in fibrosis-associated hepatocellular carcinoma
Liu X, Liu M, Wu H, Tang W, Yang W, Chan TT, Zhang L, Chen S, Xiong Z, Liang J, Wai-Yiu Si-Tou W, Shu T, Li J, Cao J, Zhong C, Sun H, Kwong TT, Leung HH, Wong J, Bo-San Lai P, To KF, Xiang T, Jao-Yiu Sung J, Chan SL, Zhou J, Sze-Lok Cheng A
2024
Impact of obesity-associated myeloid-derived suppressor cells on cancer risk and progression (Review)
Jiménez-Cortegana C, Gutiérrez-García C, Sánchez-Jiménez F, Vilariño-García T, Flores-Campos R, Pérez-Pérez A, Garnacho C, Sánchez-León ML, García-Domínguez DJ, Hontecillas-Prieto L, Palazón-Carrión N, De La Cruz-Merino L, Sánchez-Margalet V
International journal of oncology 2024
The Role of TRAIL Signaling in Cancer: Searching for New Therapeutic Strategies
Luo C, He S, Shi F, Zhou J, Shang L
Biology 2024
Dual roles of CD11b+CD33+HLA-DR-/lowCD14- myeloid-derived suppressor cells with a granulocytic morphology following allogeneic hematopoietic stem cell transplantation: from inflammation promoters to immune suppressors within 90 days
Ni M, Cui J, Yang X, Ding Y, Zhao P, Hu T, Zhan Y, Kang Q, Hu X, Zhao J, Xu Y, Chen L, Liu M, Zhao M, Zhang F, Huang S, Li Y, Yang X, Zhang L, Zhang T, Deng B, Yang B, Lu D, Wang J
Frontiers in immunology 2024
Myeloid‑derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in colorectal cancer (Review).
Zeng W, Liu H, Mao Y, Jiang S, Yi H, Zhang Z, Wang M, Zong Z
International journal of oncology 2024
Immunologic Crosstalk of Endoplasmic Reticulum Stress Signaling in Bladder Cancer.
Wan S, Li KP, Wang CY, Yang JW, Chen SY, Wang HB, Li XR, Yang L
Current cancer drug targets 2024
The role of neutrophils in osteosarcoma: insights from laboratory to clinic
Xia M, Han Y, Sun L, Li D, Zhu C, Li D
Frontiers in Immunology 2024
MDSC: a new potential breakthrough in CAR-T therapy for solid tumors
Abdalsalam NM, Ibrahim A, Saliu MA, Liu TM, Wan X, Yan D
Cell Communication and Signaling : CCS 2024
Endothelial YAP/TEAD1-CXCL17 signaling recruits myeloid-derived suppressor cells against liver ischemia-reperfusion injury
Zhang S, Sun Z, Chen Z, Bi Y, Wei S, Mao Z, Jin J, Ding Y, Wang W
Hepatology (Baltimore, Md.) 2024
The roles of arginases and arginine in immunity.
Canè S, Geiger R, Bronte V
Nature reviews. Immunology 2024
Elucidating granulocytic myeloid-derived suppressor cell heterogeneity during Staphylococcus aureus biofilm infection
Bertrand BP, Heim CE, Koepsell SA, Kielian T
Journal of leukocyte biology 2024
Endoplasmic reticulum stress mediates the myeloid-derived immune suppression associated with cancer and infectious disease
Lou X, Gao D, Yang L, Wang Y, Hou Y
Journal of Translational Medicine 2023
The Receptor for Advanced Glycation Endproducts (RAGE) and Its Ligands S100A8/A9 and High Mobility Group Box Protein 1 (HMGB1) Are Key Regulators of Myeloid-Derived Suppressor Cells
Ostrand-Rosenberg S, Huecksteadt T, Sanders K
Cancers 2023
Myeloid-Derived Suppressor Cells in Cancer and COVID-19 as Associated with Oxidative Stress
Andrés CM, Pérez de la Lastra JM, Juan CA, Plou FJ, Pérez-Lebeña E
Human vaccines 2023
5-Fluorouracil Suppresses Colon Tumor through Activating the p53-Fas Pathway to Sensitize Myeloid-Derived Suppressor Cells to FasL+ Cytotoxic T Lymphocyte Cytotoxicity
Yang Y, Zhang M, Zhang Y, Liu K, Lu C
Cancers 2023
Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding
Riera-Domingo C, Leite-Gomes E, Charatsidou I, Zhao P, Carrá G, Cappellesso F, Mourao L, De Schepper M, Liu D, Serneels J, Alameh MG, Shuvaev VV, Geukens T, Isnaldi E, Prenen H, Weissman D, Muzykantov VR, Soenen S, Desmedt C, Scheele CL, Sablina A, Di Matteo M, Martín-Pérez R, Mazzone M
Science Advances 2023
Neutrophil PAD4: how does it function in cancer beyond promoting NETosis?
Garcia-Gerique L, Nefedova Y
Oncotarget 2023
Galectin-7 reprograms skin carcinogenesis by fostering innate immune evasive programs.
Pinto NA, Abba MC, Laporte L, Pérez Sáez JM, Blidner AG, Torres NI, Morales RM, Gatto SG, Bach CA, Veigas F, García Rivello HJ, Song P, Frederiksen JH, Rasmussen LJ, Poirier F, Croci DO, Sundblad V, Rabinovich GA, Cerliani JP
Cell Death and Differentiation 2023
Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignancies
Bhardwaj V, Ansell SM
Frontiers in Cell and Developmental Biology 2023
Intranasal Delivery of Gene-Edited Microglial Exosomes Improves Neurological Outcomes after Intracerebral Hemorrhage by Regulating Neuroinflammation
Guo M, Ge X, Wang C, Yin Z, Jia Z, Hu T, Li M, Wang D, Han Z, Wang L, Xiong X, Chen F, Lei P
Brain Sciences 2023
Neutrophil diversity in inflammation and cancer
Carnevale S, Ceglie ID, Grieco G, Rigatelli A, Bonavita E, Jaillon S
Frontiers in immunology 2023
Schlafen4+-MDSC in Helicobacter-induced gastric metaplasia reveals role for GTPases
Ding L, Sheriff S, Sontz RA, Merchant JL
Frontiers in immunology 2023
Tumor-associated myeloid cells in cancer immunotherapy.
Cheng X, Wang H, Wang Z, Zhu B, Long H
Journal of Hematology & Oncology 2023
Counteracting Immunosenescence—Which Therapeutic Strategies Are Promising?
Hieber C, Grabbe S, Bros M
Biomolecules 2023
Dose-related immunomodulatory effects of recombinant TRAIL in the tumor immune microenvironment.
Wang X, Wang L, Liu W, Liu X, Jia X, Feng X, Li F, Zhu R, Yu J, Zhang H, Wu H, Wu J, Wang C, Yu B, Yu X
Journal of experimental & clinical cancer research : CR 2023
Function of reactive oxygen species in myeloid-derived suppressor cells
Huang J, Zhao Y, Zhao K, Yin K, Wang S
Frontiers in immunology 2023
CD300ld on neutrophils is required for tumour-driven immune suppression.
Wang C, Zheng X, Zhang J, Jiang X, Wang J, Li Y, Li X, Shen G, Peng J, Zheng P, Gu Y, Chen J, Lin M, Deng C, Gao H, Lu Z, Zhao Y, Luo M
Nature 2023
TRAIL promotes the polarization of human macrophages toward a proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage content
Gunalp S, Helvaci DG, Oner A, Bursalı A, Conforte A, Güner H, Karakülah G, Szegezdi E, Sag D
Frontiers in immunology 2023
Exploiting innate immunity for cancer immunotherapy
Yi M, Li T, Niu M, Mei Q, Zhao B, Chu Q, Dai Z, Wu K
Molecular Cancer 2023
DIALing-up the preclinical characterization of gene-modified adoptive cellular immunotherapies
Giardino Torchia ML, Moody G
Frontiers in immunology 2023
Engineered Adoptive T-Cell Therapies for Breast Cancer: Current Progress, Challenges, and Potential
Chamorro DF, Somes LK, Hoyos V
Cancers 2023
Modeling glioblastoma complexity with organoids for personalized treatments
Pawlowski KD, Duffy JT, Babak M, Balyasnikova IV
Trends in Molecular Medicine 2023
Inhibiting the biogenesis of myeloid-derived suppressor cells enhances immunotherapy efficacy against mammary tumor progression
Sean Colligan, Robert A Zollo, Jennifer Peresie, Elliot D Kramer, Joseph Barbi, Prashant K Singh, Jianmin Wang, Mateusz Opyrchal, David Sykes, Michael Nemeth, Scott I. Abrams
Journal of Clinical Investigation 2022
Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective
A Bleve, F Consonni, C Porta, V Garlatti, A Sica
Cancers 2022
Interaction of Immune and Cancer Cells
M Klink, I Szulc-Kielbik
2022
Neutrophils as potential therapeutic targets in hepatocellular carcinoma
D Geh, J Leslie, R Rumney, H Reeves, T Bird, D Mann
Nature Reviews Gastroenterology & Hepatology 2022
Anti-Gr-1 Antibody Provides Short-Term Depletion of MDSC in Lymphodepleted Mice with Active-Specific Melanoma Therapy
P Rose, N van den Engel, J Kovács, R Hatz, L Boon, H Winter
Human vaccines 2022
RIP3 blockade prevents immune-mediated hepatitis through a myeloid-derived suppressor cell dependent mechanism
M Liu, H Zhang, L Zhang, X Liu, S Zhou, X Wang, W Zhong, J Zhang, B Wang, J Zhao, L Zhou
International journal of biological sciences 2022
Challenges and Opportunities for Immunotherapeutic Intervention against Myeloid Immunosuppression in Glioblastoma
M Exley, S Garcia, A Zellander, J Zilberberg, D Andrews
Journal of Clinical Medicine 2022
Effects of the Anti-Tumor Agents Trabectedin and Lurbinectedin on Immune Cells of the Tumor Microenvironment
P Allavena, C Belgiovine, E Digifico, R Frapolli, M DIncalci
Frontiers in Oncology 2022
PERK reprograms hematopoietic progenitor cells to direct tumor-promoting myelopoiesis in the spleen
M Liu, C Wu, S Luo, Q Hua, H Chen, Y Weng, J Xu, H Lin, L Wang, J Li, L Zhu, Z Guo, S Zhuang, T Kang, L Zheng
Journal of Experimental Medicine 2022
Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study
P LoRusso, M Ratain, T Doi, D Rasco, M de Jonge, V Moreno, B Carneiro, L Devriese, A Petrich, D Modi, S Morgan-Lappe, S Nuthalapati, M Motwani, M Dunbar, J Glasgow, B Medeiros, E Calvo
Investigational New Drugs 2022
Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities
T Kim, E Vandsemb, R Herbst, L Chen
Nature Reviews Drug Discovery 2022
Drug Resistance in Colorectal Cancer: From Mechanism to Clinic
Wang Q, Shen X, Chen G, Du J
Cancers 2022
Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy
Joshi S, Sharabi A
Pharmacology & Therapeutics 2022
Inhibition of myeloid-derived suppressor cell arginase-1 production enhances T-cell-based immunotherapy against Cryptococcus neoformans infection
Li YN, Wang ZW, Li F, Zhou LH, Jiang YS, Yu Y, Ma HH, Zhu LP, Qu JM, Jia XM
Nature Communications 2022
Igniting Hope for Tumor Immunotherapy: Promoting the “Hot and Cold” Tumor Transition
Wei C, Ma Y, Wang F, Liao Y, Chen Y, Zhao B, Zhao Q, Wang D, Tang D
Clinical Medicine Insights. Oncology 2022
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy.
Wu Y, Yi M, Niu M, Mei Q, Wu K
Molecular Cancer 2022
The soldiers needed to be awakened: Tumor-infiltrating immune cells
Yaping W, Zhe W, Zhuling C, Ruolei L, Pengyu F, Lili G, Cheng J, Bo Z, Liuyin L, Guangdong H, Yaoling W, Niuniu H, Rui L
Frontiers in Genetics 2022
Targeting depletion of myeloid-derived suppressor cells potentiates PD-L1 blockade efficacy in gastric and colon cancers
Tang Y, Zhou C, Li Q, Cheng X, Huang T, Li F, He L, Zhang B, Tu S
OncoImmunology 2022
Anti-cancer immune responses to DNA damage response inhibitors: Molecular mechanisms and progress toward clinical translation
Carlsen L, El-Deiry WS
Frontiers in Oncology 2022
Decoding endoplasmic reticulum stress signals in cancer cells and antitumor immunity.
Salvagno C, Mandula JK, Rodriguez PC, Cubillos-Ruiz JR
Trends in Cancer 2022
Dissecting the Immunological Profiles in NSD3-Amplified LUSC through Integrative Multi-Scale Analyses.
Xu D, Liu S, Wu X, Marti TM, Dorn P, Schmid RA, Peng RW, Shu Y
Cancers 2022
cFLIP suppression and DR5 activation sensitize senescent cancer cells to senolysis.
Wang L, Jin H, Jochems F, Wang S, Lieftink C, Martinez IM, De Conti G, Edwards F, de Oliveira RL, Schepers A, Zhou Y, Zheng J, Wu W, Zheng X, Yuan S, Ling J, Jastrzebski K, Santos Dias MD, Song JY, Celie PNH, Yagita H, Yao M, Zhou W, Beijersbergen RL, Qin W, Bernards R
2022
Immunomodulatory biomaterials for implant-associated infections: from conventional to advanced therapeutic strategies
Dong J, Wang W, Zhou W, Zhang S, Li M, Li N, Pan G, Zhang X, Bai J, Zhu C
Biomaterials Research 2022
Mechanisms and Strategies to Overcome PD-1/PD-L1 Blockade Resistance in Triple-Negative Breast Cancer
Chen X, Feng L, Huang Y, Wu Y, Xie N
Cancers 2022
Characteristics of tumor microenvironment and novel immunotherapeutic strategies for non-small cell lung cancer
Wang F, Yang M, Luo W, Zhou Q
2022
Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines
Xie X, Lee J, Fuson JA, Liu H, Iwase T, Yun K, Margain C, Tripathy D, Ueno NT
Expert opinion on therapeutic targets 2022
Distinct mechanisms govern populations of myeloid-derived suppressor cells in chronic viral infection and cancer
Evgenii N Tcyganov, Shino Hanabuchi, Ayumi Hashimoto, David Campbell, Gozde Kar, Timothy W F Slidel, Corinne Cayatte, Aimee Landry, Fernanda Pilataxi, Susana Hayes, Brian Dougherty, Kristin C. Hicks, Kathy Mulgrew, Chih-Hang A Tang, Chih-Chi A. Hu, Wei Guo, Sergei Grivennikov, Mohammed-Alkhatim A. Ali, Jean-Christophe Beltra, E. John Wherry, Yulia Nefedova, Dmitry I. Gabrilovich
Journal of Clinical Investigation 2021
Myeloid-Derived Suppressor Cells: Implications in the Resistance of Malignant Tumors to T Cell-Based Immunotherapy
H Shi, K Li, Y Ni, X Liang, X Zhao
Frontiers in Cell and Developmental Biology 2021
Novel Characterization of Myeloid-Derived Suppressor Cells in Tumor Microenvironment
Y Li, H He, R Jihu, J Zhou, R Zeng, H Yan
Frontiers in Cell and Developmental Biology 2021
Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
K Li, H Shi, B Zhang, X Ou, Q Ma, Y Chen, P Shu, D Li, Y Wang
Signal Transduction and Targeted Therapy 2021
The role of myeloid‐derived suppressor cells in gastrointestinal cancer
C Cui, P Lan, L Fu
2021
Immunosuppressive Effects of Myeloid-Derived Suppressor Cells in Cancer and Immunotherapy
M Krishnamoorthy, L Gerhardt, SM Vareki
Cells 2021
Endoplasmic Reticulum Quality Control in Immune Cells
Y Jiang, Z Tao, H Chen, S Xia
Frontiers in Cell and Developmental Biology 2021
Tumor-related stress regulates functional plasticity of MDSCs
JK Mandula, PC Rodriguez
Cellular Immunology 2021
Unexpected PD‐L1 immune evasion mechanism in TNBC, ovarian, and other solid tumors by DR5 agonist antibodies
T Mondal, GN Shivange, RG Tihagam, E Lyerly, M Battista, D Talwar, R Mosavian, K Urbanek, NS Rashid, JC Harrell, PD Bos, EB Stelow, MS Stack, S Bhatnagar, J TushirSingh
EMBO Molecular Medicine 2021
Roles of Neutrophils in Glioma and Brain Metastases
YJ Lin, KC Wei, PY Chen, M Lim, TL Hwang
Frontiers in immunology 2021
Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy
C Zalfa, S Paust
Frontiers in immunology 2021
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
F Veglia, E Sanseviero, DI Gabrilovich
Nature Reviews Immunology 2021
Novel Combinatorial Approaches to Tackle the Immunosuppressive Microenvironment of Prostate Cancer
EG Shackleton, HY Ali, M Khan, GA Pockley, SE McArdle
Cancers 2021
Combined Effects of Myeloid Cells in the Neuroblastoma Tumor Microenvironment
J Frosch, I Leontari, J Anderson
Cancers 2021
Icaritin Induces Anti-tumor Immune Responses in Hepatocellular Carcinoma by Inhibiting Splenic Myeloid-Derived Suppressor Cell Generation
H Tao, M Liu, Y Wang, S Luo, Y Xu, B Ye, L Zheng, K Meng, L Li
Frontiers in immunology 2021
Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway
K Alicea-Torres, E Sanseviero, J Gui, J Chen, F Veglia, Q Yu, L Donthireddy, A Kossenkov, C Lin, S Fu, C Mulligan, B Nam, G Masters, F Denstman, J Bennett, N Hockstein, A Rynda-Apple, Y Nefedova, SY Fuchs, DI Gabrilovich
Nature Communications 2021
Targeting myeloid-derived suppressor cells for cancer therapy
H Tang, H Li, Z Sun
Cancer biology & medicine 2021
Immunopathogenesis of Craniotomy Infection and Niche-Specific Immune Responses to Biofilm
SD de Morais, G Kak, JP Menousek, T Kielian
Frontiers in immunology 2021
Targeting MDSC for Immune-Checkpoint Blockade in Cancer Immunotherapy: Current Progress and New Prospects
T Li, T Liu, W Zhu, S Xie, Z Zhao, B Feng, H Guo, R Yang
Clinical Medicine Insights. Oncology 2021
Beyond immunosuppressive effects: dual roles of myeloid-derived suppressor cells in bone-related diseases
Z Ling, C Yang, J Tan, C Dou, Y Chen
Cellular and Molecular Life Sciences 2021
Asah2 Represses the p53–Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis
H Zhu, JD Klement, C Lu, PS Redd, D Yang, AD Smith, DB Poschel, J Zou, D Liu, PG Wang, D Ostrov, N Coant, YA Hannun, AH Colby, MW Grinstaff, K Liu
Journal of immunology (Baltimore, Md. : 1950) 2021
Crosstalk Between the Tumor Microenvironment and Cancer Cells: A Promising Predictive Biomarker for Immune Checkpoint Inhibitors
X Li, Y Yang, Q Huang, Y Deng, F Guo, G Wang, M Liu
Frontiers in Cell and Developmental Biology 2021
Reprogramming immunosuppressive myeloid cells by activated T cells promotes the response to anti-PD-1 therapy in colorectal cancer
J Chen, HW Sun, YY Yang, HT Chen, XJ Yu, WC Wu, YT Xu, LL Jin, XJ Wu, J Xu, L Zheng
Signal Transduction and Targeted Therapy 2021
Granulocytes and Cells of Granulocyte Origin—The Relevant Players in Colorectal Cancer
I Siemińska, E Poljańska, J Baran
International journal of molecular sciences 2021
Dexamethasone and lactoferrin induced PMN-MDSCs relieved inflammatory adverse events of anti-cancer therapy without tumor promotion
X Li, J Chen, YJ Chen, YD Qiao, LY Zhao, N Jiang, XY Wu, YF Xing
2021
MDSC: Markers, development, states, and unaddressed complexity
S Hegde, AM Leader, M Merad
Immunity 2021
GLUT1 Expression in Tumor-Associated Neutrophils Promotes Lung Cancer Growth and Resistance to Radiotherapy
PB Ancey, C Contat, G Boivin, S Sabatino, J Pascual, N Zangger, JY Perentes, S Peters, ED Abel, DG Kirsch, JC Rathmell, MC Vozenin, E Meylan
Cancer research 2021
Therapeutic Values of Myeloid-Derived Suppressor Cells in Hepatocellular Carcinoma: Facts and Hopes
Y Wang, T Zhang, M Sun, X Ji, M Xie, W Huang, L Xia
Cancers 2021
Myeloid-derived suppressor cells and the pathogenesis of human immunodeficiency virus infection
MM Yaseen, NM Abuharfeil, H Darmani
Open Biology 2021
Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer
SA Nalawade, P Shafer, P Bajgain, MK McKenna, A Ali, L Kelly, J Joubert, S Gottschalk, N Watanabe, A Leen, R Parihar, JF Valdes, V Hoyos
Journal for ImmunoTherapy of Cancer 2021
Polymorphonuclear myeloid-derived suppressor cells limit antigen cross-presentation by dendritic cells in cancer
Alessio Ugolini, Vladimir Tyurin, Yulia Tyurina, Evgenii Tsyganov, Laxminarasimha Donthireddy, Valerian E Kagan, Dmitry I. Gabrilovich, Filippo Veglia
JCI Insight 2020
Autocrine IL6-Mediated Activation of the STAT3–DNMT Axis Silences the TNFα–RIP1 Necroptosis Pathway to Sustain Survival and Accumulation of Myeloid-Derived Suppressor Cells
AD Smith, C Lu, D Payne, AV Paschall, JD Klement, PS Redd, ML Ibrahim, D Yang, Q Han, Z Liu, H Shi, TJ Hartney, A Nayak-Kapoor, K Liu
Cancer research 2020
Reactive Myelopoiesis Triggered by Lymphodepleting Chemotherapy Limits the Efficacy of Adoptive T Cell Therapy
P Innamarato, K Kodumudi, S Asby, B Schachner, ML Hall, A Mackay, D Wiener, M Beatty, L Nagle, BC Creelan, AA Sarnaik, S Pilon-Thomas
Molecular Therapy 2020
Stress Management: Death Receptor Signalling and Cross-Talks with the Unfolded Protein Response in Cancer
E Lafont
Cancers 2020
Myeloid-driven mechanisms as barriers to antitumor CD8+ T cell activity
SH Colligan, SL Tzetzo, SI Abrams
Molecular Immunology 2020
The Engagement Between MDSCs and Metastases: Partners in Crime
R Trovato, S Canè, V Petrova, S Sartoris, S Ugel, FD Sanctis
Frontiers in Oncology 2020
The Emerging Roles of Endoplasmic Reticulum Stress in Balancing Immunity and Tolerance in Health and Diseases: Mechanisms and Opportunities
A Li, NJ Song, BP Riesenberg, Z Li
Frontiers in immunology 2020
Lifting the innate immune barriers to antitumor immunity
CV Rothlin, S Ghosh
Journal for ImmunoTherapy of Cancer 2020
Neutrophils as emerging therapeutic targets
T Németh, M Sperandio, A Mócsai
Nature Reviews Drug Discovery 2020
Reactive Myelopoiesis and the Onset of Myeloid-Mediated Immune Suppression: Implications for Adoptive Cell Therapy
P Innamarato, S Pilon-Thomas
Cellular Immunology 2020
IRE1α regulates macrophage polarization, PD-L1 expression, and tumor survival
A Batista, JJ Rodvold, S Xian, SC Searles, A Lew, T Iwawaki, G Almanza, TC Waller, J Lin, K Jepsen, H Carter, M Zanetti, TC Freeman
PLoS Biology 2020
Unraveling the regulatory role of endoplasmic-reticulum-associated degradation in tumor immunity
X Qin, WD Denton, LN Huiting, KS Smith, H Feng
Critical Reviews in Biochemistry and Molecular Biology 2020
The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment
Y Mi, N Guo, J Luan, J Cheng, Z Hu, P Jiang, W Jin, X Gao
Frontiers in immunology 2020
Neutrophil diversity and plasticity in tumour progression and therapy
S Jaillon, A Ponzetta, DD Mitri, A Santoni, R Bonecchi, A Mantovani
Nature Reviews Cancer 2020
The complexity of neutrophils in health and disease: Focus on cancer
S Carnevale, S Ghasemi, A Rigatelli, S Jaillon
Seminars in Immunology 2020
Interplay between endoplasmic reticulum stress and non-coding RNAs in cancer
T Zhao, J Du, H Zeng
Journal of Hematology & Oncology 2020
Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation
Y Yang, C Li, T Liu, X Dai, AV Bazhin
Frontiers in immunology 2020
Myeloid-Derived Suppressor Cells in Colorectal Cancer
I Sieminska, J Baran
Frontiers in immunology 2020
The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion
PD Cicco, G Ercolano, A Ianaro
Frontiers in immunology 2020
Endoplasmic reticulum stress signals in the tumour and its microenvironment
, JR Cubillos-Ruiz
Nature Reviews Cancer 2020
Roles of HMGB1 in regulating myeloid-derived suppressor cells in the tumor microenvironment
S Jin, Z Yang, X Hao, W Tang, W Ma, H Zong
Biomarker Research 2020
Developmental Pathways of Myeloid-Derived Suppressor Cells in Neoplasia
SI Abrams
Cellular Immunology 2020
Transmissible Endoplasmic Reticulum Stress: A Novel Perspective on Tumor Immunity
Z Jiang, G Zhang, L Huang, Y Yuan, C Wu, Y Li
Frontiers in Cell and Developmental Biology 2020
Myeloid-derived suppressor cells—new and exciting players in lung cancer
Z Yang, J Guo, L Weng, W Tang, S Jin, W Ma
Journal of Hematology & Oncology 2020
The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling
E Mohamed, RA Sierra, J Trillo-Tinoco, Y Cao, P Innamarato, KK Payne, A de Mingo Pulido, J Mandula, S Zhang, P Thevenot, S Biswas, SK Abdalla, TL Costich, K Hänggi, CM Anadon, ER Flores, EB Haura, S Mehrotra, S Pilon-Thomas, B Ruffell, DH Munn, JR Cubillos-Ruiz, JR Conejo-Garcia, PC Rodriguez
Immunity 2020
ER Stress Regulates Immunosuppressive Function of Myeloid Derived Suppressor Cells in Leprosy that Can Be Overcome in the Presence of IFN-γ
KM Kelly-Scumpia, A Choi, R Shirazi, H Bersabe, E Park, PO Scumpia, MT Ochoa, J Yu, F Ma, M Pellegrini, RL Modlin
iScience 2020
KSHV infection skews macrophage polarisation towards M2-like/TAM and activates Ire1 α-XBP1 axis up-regulating pro-tumorigenic cytokine release and PD-L1 expression
MS Montani, L Falcinelli, R Santarelli, M Granato, MA Romeo, N Cecere, R Gonnella, G DOrazi, A Faggioni, M Cirone
British Journal of Cancer 2020
The future of cancer immunotherapy: microenvironment-targeting combinations
YR Murciano-Goroff, AB Warner, JD Wolchok
Cell Research 2020
Dyslipidemic Diet Induces Mobilization of Peripheral Neutrophils and Monocytes That Exacerbate Hemorrhagic Brain Injury and Neuroinflammation
X Li, X Cheng, X Wang, Q Liu, H Ma, M Li
Frontiers in cellular neuroscience 2020
Upregulated TRAIL and Reduced DcR2 Mediate Apoptosis of Decidual PMN-MDSC in Unexplained Recurrent Pregnancy Loss
C Li, X Zhang, X Kang, C Chen, F Guo, Q Wang, A Zhao
Frontiers in immunology 2020
Lian Hua Qing Wen Capsules, a Potent Epithelial Protector in Acute Lung Injury Model, Block Proapoptotic Communication Between Macrophages, and Alveolar Epithelial Cells
Q Li, Q Ran, L Sun, J Yin, T Luo, L Liu, Z Zhao, Q Yang, Y Li, Y Chen, X Weng, Y Wang, W Cai, X Zhu
Frontiers in pharmacology 2020
The Development and Homing of Myeloid-Derived Suppressor Cells: From a Two-Stage Model to a Multistep Narrative
N Karin
Frontiers in immunology 2020
Deciphering and Reversing Immunosuppressive Cells in the Treatment of Hepatocellular Carcinoma
Yu SJ, Greten TF
2020
Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC
Julia Kargl, Xiaodong Zhu, Huajia Zhang, grace hy yang, Travis J Friesen, melissa shipley, Dean Y. Maeda, John A. Zebala, Jill McKay-Fleisch, Gavin Meredith, Afshin Mashadi-Hossein, Christina Baik, Robert H. Pierce, Mary W Redman, Jeffrey C. Thompson, Steven M Albelda, Hamid Bolouri, A McGarry Houghton
JCI Insight 2019
TRAIL and FasL Functions in Cancer and Autoimmune Diseases: Towards an Increasing Complexity
Rossin, Miloro, Hueber
Cancers 2019

Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives


LC Lu, CJ Chang, CH Hsu
Journal of Hepatocellular Carcinoma 2019
Proteostasis In The Endoplasmic Reticulum: Road to Cure
Nam, Jeon
Cancers 2019
The Role of TRAIL/DRs in the Modulation of Immune Cells and Responses
D Sag, ZO Ayyildiz, S Gunalp, G Wingender
Cancers 2019
Immunosurveillance of cancer cell stress
S Lorenzo-Herrero, C Sordo-Bahamonde, S González, A López-Soto
2019
Phenotypic and transcriptomic characterization of canine myeloid-derived suppressor cells
MR Goulart, SI Hlavaty, YM Chang, G Polton, A Stell, J Perry, Y Wu, E Sharma, J Broxholme, AC Lee, B Szladovits, M Turmaine, J Gribben, D Xia, OA Garden
Scientific Reports 2019
GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment
MJ Halaby, K Hezaveh, S Lamorte, MT Ciudad, A Kloetgen, BL MacLeod, M Guo, A Chakravarthy, TD Medina, S Ugel, A Tsirigos, V Bronte, DH Munn, TJ Pugh, DD Carvalho, MO Butler, PS Ohashi, DG Brooks, TL McGaha
Science Immunology 2019
ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression
Y Cao, J Trillo-Tinoco, RA Sierra, C Anadon, W Dai, E Mohamed, L Cen, TL Costich, A Magliocco, D Marchion, R Klar, S Michel, F Jaschinski, RR Reich, S Mehrotra, JR Cubillos-Ruiz, DH Munn, JR Conejo-Garcia, PC Rodriguez
Nature Communications 2019
MDSCs: Key Criminals of Tumor Pre-metastatic Niche Formation
Y Wang, Y Ding, N Guo, S Wang
Frontiers in immunology 2019
Tumor-derived exosomes, myeloid-derived suppressor cells, and tumor microenvironment
X Tian, H Shen, Z Li, T Wang, S Wang
Journal of Hematology & Oncology 2019
Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches
A Thyagarajan, MS Alshehri, KL Miller, CM Sherwin, JB Travers, RP Sahu
Cancers 2019
Temporal and spatial profile of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) in ischemic stroke in mice
T Kawano, M Shimamura, H Nakagami, H Kanki, T Sasaki, H Mochizuki, M Mogi
PloS one 2019
Myeloid Derived Suppressor Cells Expansion Persists After Early ART and May Affect CD4 T Cell Recovery
C Agrati, N Tumino, V Bordoni, C Pinnetti, A Sabatini, A Amendola, I Abbate, P Lorenzini, A Mondi, R Casetti, E Cimini, G Grassi, A Antinori, A Sacchi
Frontiers in immunology 2019
Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates
L Cassetta, ES Baekkevold, S Brandau, A Bujko, MA Cassatella, A Dorhoi, C Krieg, A Lin, K Loré, O Marini, JW Pollard, M Roussel, P Scapini, V Umansky, GJ Adema
Cancer Immunology, Immunotherapy 2019
Polymorphonuclear myeloid-derived suppressor cells attenuate allergic airway inflammation by negatively regulating group 2 innate lymphoid cells
Y Cao, Y He, X Wang, Y Liu, K Shi, Z Zheng, X Su, A Lei, J He, J Zhou
Immunology 2019
Endoplasmic Reticulum Stress Contributes to Mitochondrial Exhaustion of CD8 + T Cells
KE Hurst, KA Lawrence, MT Essman, ZJ Walton, LR Leddy, JE Thaxton
Cancer immunology research 2019
The IRE1 endoplasmic reticulum stress sensor activates natural killer cell immunity in part by regulating c-Myc
H Dong, NM Adams, Y Xu, J Cao, DS Allan, JR Carlyle, , JC Sun, LH Glimcher
Nature Immunology 2019
Targeting myeloid-derived suppressor cells in combination with primary mammary tumor resection reduces metastatic growth in the lungs
M Bosiljcic, RA Cederberg, MJ Hamilton, NE LePard, BT Harbourne, JL Collier, EC Halvorsen, R Shi, SE Franks, AY Kim, JP Banáth, M Hamer, FM Rossi, KL Bennewith
Breast Cancer Research 2019
Bacterial Killing Activity of Polymorphonuclear Myeloid-Derived Suppressor Cells Isolated From Tumor-Bearing Dogs
SI Hlavaty, YM Chang, RP Orth, M Goulian, PJ Planet, DH Thamm, JA Punt, OA Garden
Frontiers in immunology 2019
Endoplasmic Reticulum Stress Signaling as a Therapeutic Target in Malignant Pleural Mesothelioma
Xu, Yang, Yang, Berezowska, Gao, Liang, Marti, Hall, Dorn, Kocher, Schmid, Peng
Cancers 2019
The inhibitor of autophagy SBI‑0206965 aggravates atherosclerosis through decreasing myeloid‑derived suppressor cells
B Wang, G Dong, Q Zhang, F Yan, Z Li, C Li, H Zhang, Q Ma, J Dai, C Si, H Xiong
Experimental and therapeutic medicine 2019
Pharmacological Targeting of MYC-Regulated IRE1/XBP1 Pathway Suppresses MYC-Driven Breast Cancer
Na Zhao, Jin Cao, Longyong Xu, Qianzi Tang, Lacey Dobrolecki, Xiangdong Lyu, Manisha Talukdar, Yang Lu, Xiaoran Wang, Dorothy Hu, Qing Shi, Yu Xiang, Yunfei Wang, Xia Liu, Wen Bu, Yi Jiang, Mingzhou Li, Yingyun Gong, Zheng Sun, Haoqiang Ying, Bo Yuan, Xia Lin, Xin-Hua Feng, Sean Hartig, Feng Li, Haifa Shen, Yiwen Chen, Leng Han, Qingping Zeng, John Patterson, Benny Abraham Kaipparettu, NAGIREDDY PUTLURI, Frank Sicheri, Jeffrey Rosen, Michael T. Lewis, Xi Chen
Journal of Clinical Investigation 2018
Spleen Mediates A Distinct Hematopoietic Progenitor Response Supporting Tumor-Promoting Myelopoiesis
Chong Wu, Huiheng Ning, Mingyu Liu, Jie Lin, Shufeng Luo, Wenjie Zhu, Jing Xu, Wen-Chao Wu, Jing Liang, Chun-Kui Shao, Jiaqi Ren, Bin Wei, Jun Cui, Min-Shan Chen, Limin Zheng
Journal of Clinical Investigation 2018
Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells
Themis Alissafi, Aikaterini Hatzioannou, Konstantinos Mintzas, Roza Maria Barouni, Aggelos Banos, Sundary Sormendi, Alexandros Polyzos, Maria Xilouri, Ben Wielockx, Helen Gogas, Panayotis Verginis
Journal of Clinical Investigation 2018
Distal airway microbiome is associated with immunoregulatory myeloid cell responses in lung transplant recipients
NS Sharma, KM Wille, S Athira, D Zhi, KP Hough, E Diaz-Guzman, K Zhang, R Kumar, S Rangarajan, P Eipers, Y Wang, RK Srivastava, JV Dager, M Athar, C Morrow, CW Hoopes, DD Chaplin, VJ Thannickal, JS Deshane
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2018
Plasticity of myeloid-derived suppressor cells in cancer
E Tcyganov, J Mastio, E Chen, DI Gabrilovich
Current Opinion in Immunology 2018
Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation
YM He, X Li, M Perego, Y Nefedova, AV Kossenkov, EA Jensen, V Kagan, YF Liu, SY Fu, QJ Ye, YH Zhou, L Wei, DI Gabrilovich, J Zhou
Nature Medicine 2018
Protein Quality Control in the Endoplasmic Reticulum and Cancer
HW Moon, HG Han, YJ Jeon
International journal of molecular sciences 2018
S100A4 Protects Myeloid-Derived Suppressor Cells from Intrinsic Apoptosis via TLR4–ERK1/2 Signaling
Q Li, C Dai, R Xue, P Wang, L Chen, Y Han, U Erben, Z Qin
Frontiers in immunology 2018
Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in Tuberculosis
N du Plessis, LA Kotze, V Leukes, G Walzl
Frontiers in Cellular and Infection Microbiology 2018
The cellular metabolic landscape in the tumor milieu regulates the activity of myeloid infiltrates
E Mohamed, AA Al-Khami, PC Rodriguez
Cellular and Molecular Immunology 2018
Monocytic Myeloid-Derived Suppressor Cells in Chronic Infections
A Dorhoi, ND Plessis
Frontiers in immunology 2018
Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells
J Zhou, Y Nefedova, A Lei, D Gabrilovich
Seminars in Immunology 2018
Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment
S Ostrand-Rosenberg, C Fenselau
Journal of immunology (Baltimore, Md. : 1950) 2018
Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy
EJ Clappaert, A Murgaski, HV Damme, M Kiss, D Laoui
Frontiers in immunology 2018
Myeloid-derived suppressor cells coming of age
F Veglia, M Perego, D Gabrilovich
Nature Immunology 2018
Inhibition of Casein Kinase 2 Disrupts Differentiation of Myeloid Cells in Cancer and Enhances the Efficacy of Immunotherapy in Mice
A Hashimoto, C Gao, J Mastio, A Kossenkov, SI Abrams, AV Purandare, H Desilva, S Wee, J Hunt, M Jure-Kunkel, DI Gabrilovich
Cancer research 2018
Myeloid-derived Suppressor Cells Are Necessary for Development of Pulmonary Hypertension
AJ Bryant, V Shenoy, C Fu, G Marek, KJ Lorentsen, EL Herzog, ML Brantly, D Avram, EW Scott
American journal of respiratory cell and molecular biology 2018
Unique pattern of neutrophil migration and function during tumor progression
S Patel, S Fu, J Mastio, GA Dominguez, A Purohit, A Kossenkov, C Lin, K Alicea-Torres, M Sehgal, Y Nefedova, J Zhou, LR Languino, C Clendenin, RH Vonderheide, C Mulligan, B Nam, N Hockstein, G Masters, M Guarino, ZT Schug, DC Altieri, DI Gabrilovich
Nature Immunology 2018
Tumor regulation of the tissue environment in the liver
T Eggert, TF Greten
Pharmacology & Therapeutics 2017
Unfolded Protein Response of the Endoplasmic Reticulum in Tumor Progression and Immunogenicity
YS Yoo, HG Han, YJ Jeon
Oxidative medicine and cellular longevity 2017
IRF7 regulates the development of granulocytic myeloid-derived suppressor cells through S100A9 transrepression in cancer
Q Yang, X Li, H Chen, Y Cao, Q Xiao, Y He, J Wei, J Zhou
Oncogene 2017
Myeloid-Derived Suppressor Cells
DI Gabrilovich
Cancer immunology research 2017
Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer
JR Cubillos-Ruiz, SE Bettigole, LH Glimcher
Cell 2017
Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis
SL Jian, WW Chen, YC Su, YW Su, TH Chuang, SC Hsu, LR Huang
Cell Death and Disease 2017
Role of myeloid-derived suppressor cells in allogeneic hematopoietic cell transplantation
BH Koehn, BR Blazar
Journal of leukocyte biology 2017
IRF-8 regulates expansion of myeloid-derived suppressor cells and Foxp3+ regulatory T cells and modulates Th2 immune responses to gastrointestinal nematode infection
RM Valanparambil, M Tam, PP Gros, JP Auger, M Segura, P Gros, A Jardim, TG Geary, K Ozato, MM Stevenson, P Loke
PLoS pathogens 2017
SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor Cells
PS Redd, ML Ibrahim, JD Klement, SK Sharman, AV Paschall, D Yang, A Nayak-Kapoor, K Liu
Cancer research 2017
Unfolding anti-tumor immunity: ER stress responses sculpt tolerogenic myeloid cells in cancer
JR Cubillos-Ruiz, E Mohamed, PC Rodriguez
Journal for ImmunoTherapy of Cancer 2017
Endoplasmic reticulum stress regulates tumor growth and anti-tumor immunity: a promising opportunity for cancer immunotherapy
E Mohamed, Y Cao, PC Rodriguez
Cancer Immunology, Immunotherapy 2017
First-in-human study of the antibody DR5 agonist DS-8273a in patients with advanced solid tumors
A Forero, JC Bendell, P Kumar, L Janisch, M Rosen, Q Wang, C Copigneaux, M Desai, G Senaldi, ML Maitland
Investigational New Drugs 2017
Intercellular transmission of the unfolded protein response promotes survival and drug resistance in cancer cells
JJ Rodvold, KT Chiu, N Hiramatsu, JK Nussbacher, V Galimberti, NR Mahadevan, K Willert, JH Lin, M Zanetti
Science signaling 2017
Selective NLRP3 (Pyrin Domain–Containing Protein 3) Inflammasome Inhibitor Reduces Brain Injury After Intracerebral Hemorrhage
H Ren, Y Kong, Z Liu, D Zang, X Yang, K Wood, M Li, Q Liu
Stroke; a journal of cerebral circulation 2017
Endoplasmic reticulum stress induced LOX-1 + CD15 + polymorphonuclear myeloid-derived suppressor cells in hepatocellular carcinoma
J Nan, YF Xing, B Hu, JX Tang, HM Dong, YM He, DY Ruan, QJ Ye, JR Cai, XK Ma, J Chen, XR Cai, ZX Lin, XY Wu, X Li
Immunology 2017
Myeloid-derived cells in prostate cancer progression: phenotype and prospective therapies
Z Lopez-Bujanda, CG Drake
Journal of leukocyte biology 2017
Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody
GA Dominguez, T Condamine, S Mony, A Hashimoto, F Wang, Q Liu, A Forero, J Bendell, R Witt, N Hockstein, P Kumar, DI Gabrilovich
Clinical cancer research 2016
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
V Bronte, S Brandau, SH Chen, MP Colombo, AB Frey, TF Greten, S Mandruzzato, PJ Murray, A Ochoa, S Ostrand-Rosenberg, PC Rodriguez, A Sica, V Umansky, RH Vonderheide, DI Gabrilovich
Nature Communications 2016
Bone marrow PMN-MDSCs and neutrophils are functionally similar in protection of multiple myeloma from chemotherapy
IR Ramachandran, T Condamine, C Lin, SE Herlihy, A Garfall, DT Vogl, DI Gabrilovich, Y Nefedova
Cancer Letters 2016
High-mobility group box protein 1 promotes the survival of myeloid-derived suppressor cells by inducing autophagy
KH Parker, LA Horn, S Ostrand-Rosenberg
Journal of leukocyte biology 2016
Myeloid-Derived Suppressor Cell Survival and Function Are Regulated by the Transcription Factor Nrf2
DW Beury, KA Carter, C Nelson, P Sinha, E Hanson, M Nyandjo, PJ Fitzgerald, A Majeed, N Wali, S Ostrand-Rosenberg
Journal of immunology (Baltimore, Md. : 1950) 2016
Targeting Immune Regulatory Networks to Counteract Immune Suppression in Cancer
C Camisaschi, V Vallacchi, E Vergani, M Tazzari, S Ferro, A Tuccitto, O Kuchuk, E Shahaj, R Sulsenti, C Castelli, M Rodolfo, L Rivoltini, V Huber
Human vaccines 2016
Peptidoglycan from the gut microbiota governs the lifespan of circulating phagocytes at homeostasis
CB Hergott, AM Roche, E Tamashiro, TB Clarke, AG Bailey, A Laughlin, FD Bushman, JN Weiser
Blood 2016
Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients
T Condamine, GA Dominguez, JI Youn, AV Kossenkov, S Mony, K Alicea-Torres, E Tcyganov, A Hashimoto, Y Nefedova, C Lin, S Partlova, A Garfall, DT Vogl, X Xu, SC Knight, G Malietzis, GH Lee, E Eruslanov, SM Albelda, X Wang, JL Mehta, M Bewtra, A Rustgi, N Hockstein, R Witt, G Masters, B Nam, D Smirnov, MA Sepulveda, DI Gabrilovich
Science Immunology 2016
Myeloid-Derived Suppressor Cells in Bacterial Infections
M Ost, A Singh, A Peschel, R Mehling, N Rieber, D Hartl
Frontiers in Cellular and Infection Microbiology 2016
Ceramide activates lysosomal cathepsin B and cathepsin D to attenuate autophagy and induces ER stress to suppress myeloid-derived suppressor cells
F Liu, X Li, C Lu, A Bai, J Bielawski, A Bielawska, B Marshall, PV Schoenlein, IO Lebedyeva, K Liu
Oncotarget 2016
Primary Heligmosomoides polygyrus bakeri infection induces myeloid-derived suppressor cells that suppress CD4+ Th2 responses and promote chronic infection
RM Valanparambil, M Tam, A Jardim, TG Geary, MM Stevenson
Mucosal Immunology 2016
TNFα-induced M-MDSCs promote transplant immune tolerance via nitric oxide
F Yang, Y Li, T Wu, N Na, Y Zhao, W Li, C Han, L Zhang, J Lu, Y Zhao
Journal of Molecular Medicine 2016
TNF-related apoptosis-inducing ligand deficiency enhances survival in murine colon ascendens stent peritonitis
K Beyer, L Stollhof, C Poetschke, W Bernstorff, LI Partecke, S Diedrich, S Maier, B Broeker, CD Heidecke
Journal of inflammation research 2016
Functional TRAIL receptors in monocytes and tumor-associated macrophages: A possible targeting pathway in the tumor microenvironment
M Liguori, C Buracchi, F Pasqualini, F Bergomas, S Pesce, M Sironi, F Grizzi, A Mantovani, C Belgiovine, P Allavena
Oncotarget 2016
Myeloid-derived suppressor cells in the tumor microenvironment: things are not always what they seem
Douglas Marvel, Dmitry I. Gabrilovich
Journal of Clinical Investigation 2015
Transcriptional regulation of myeloid-derived suppressor cells
T Condamine, J Mastio, DI Gabrilovich
Journal of leukocyte biology 2015
The evolving paradigm of cell-nonautonomous UPR-based regulation of immunity by cancer cells
M Zanetti, JJ Rodvold, NR Mahadevan
Oncogene 2015
The phenotype, development and biological function of myeloid-derived suppressor cells: Molecular regulation of MDSCs
Y Zhao, T Wu, S Shao, B Shi, Y Zhao
OncoImmunology 2015
The immunobiology of myeloid-derived suppressor cells in cancer
M Motallebnezhad, F Jadidi-Niaragh, ES Qamsari, S Bagheri, T Gharibi, M Yousefi
Tumor Biology 2015
Advances in Cancer Research
MR Rutkowski, N Svoronos, A Perales-Puchalt, JR Conejo-Garcia
Advances in cancer research 2015
Metformin induces ER stress-dependent apoptosis through miR-708-5p/NNAT pathway in prostate cancer
J Yang, J Wei, Y Wu, Z Wang, Y Guo, P Lee, X Li
Oncogenesis 2015
Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease
YJ Kim, SY Chang, HJ Ko
Intestinal Research 2015
Antigen spreading-induced CD8+T cells confer protection against the lethal challenge of wild-type malignant mesothelioma by eliminating myeloid-derived suppressor cells
Yu Z, Tan Z, Lee BK, Tang J, Wu X, Cheung KW, Lok Lo NT, Man K, Liu L, Chen Z
Oncotarget 2015
The impact of the endoplasmic reticulum protein-folding environment on cancer development
M Wang, RJ Kaufman
Nature Reviews Cancer 2014
The Stress-Response Sensor Chop Regulates the Function and Accumulation of Myeloid-Derived Suppressor Cells in Tumors
PT Thevenot, RA Sierra, PL Raber, AA Al-Khami, J Trillo-Tinoco, P Zarreii, AC Ochoa, Y Cui, L Del Valle, PC Rodriguez
Immunity 2014
Myeloid-Derived Suppressor Activity Is Mediated by Monocytic Lineages Maintained by Continuous Inhibition of Extrinsic and Intrinsic Death Pathways
JM Haverkamp, AM Smith, R Weinlich, CP Dillon, JE Qualls, G Neale, B Koss, Y Kim, V Bronte, MJ Herold, DR Green, JT Opferman, PJ Murray
Immunity 2014
Myeloid-Derived Suppressor Cells as Therapeutic Target in Hematological Malignancies
KD Veirman, EV Valckenborgh, Q Lahmar, X Geeraerts, ED Bruyne, E Menu, IV Riet, K Vanderkerken, JA van Ginderachter
Frontiers in Oncology 2014
Characterization of the Murine Myeloid Precursor Cell Line MuMac-E8
S Fricke, C Pfefferkorn, D Wolf, S Riemschneider, J Kohlschmidt, N Hilger, C Fueldner, J Knauer, U Sack, F Emmrich, J Lehmann, P Rameshwar
PloS one 2014
A highly efficient tumor-infiltrating MDSC differentiation system for discovery of anti-neoplastic targets, which circumvents the need for tumor establishment in mice
Liechtenstein T, Perez-Janices N, Gato M, Caliendo F, Kochan G, Blanco-Luquin I, Van der Jeught K, Arce F, Guerrero-Setas D, Fernandez-Irigoyen J, Santamaria E, Breckpot K, Escors D
Oncotarget 2014

← Previous 1 2 3 … 9 10 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 2 news outlets
Posted by 2 X users
Referenced in 2 patents
201 readers on Mendeley
See more details